Wow that's interesting narmac. VERU has 80.05 mil shares outstanding and there was just over 350 mil shares traded today...4.3X's turnover in one day. That happens to be about US$ 1.15 billion or C$ 1.43 billion. With an estimate of 270 mil shrs outstanding an equal value for RVX would be about C$5.25 for COVID only.
That's a long way from the increases of both PFE and MRK when they came out with their COVID therapies. I wonder what the safety profile of this drug is compared to APB.
tada